Central Nervous System Stimulants
• These Drugs Primarily Stimulate The Nervous System
And Improve Certain Brain Functions.
• Relatively Nonspecific Drugs In Action And Affect All
Parts Of Body When Given In Sufficient Dose.
• Adverse Side Effects Are Seen And Potential Of Abuse.
So only few drugs are in practice.
CLASSIFICATION:
1. Psychostimulants/Cerebral Stimulants
 Xanthines/Methylxanthines
Eg: Caffeine
 Amfetamines
Eg: Amfetamine And Methamphetamine
 Norepinephrine-dopamine Reuptake Inhibitors
Eg: Methylphenidate
 Ampakines
Eg: Ampalex And Cardophen
 Miscellaneous Drugs
Eg: Modafinil And Adrafinil
2. Brain Stem Stimulants / Analeptics
Eg: Doxapram, Bemegride.
3. Convulsants
Eg: Strychine, Brucine, picrotoxin.
4. Psychotomimetics / Hallucinogen
Eg: Cannabis, LSD, Mescaline.
1. PSYCHOSTIMULANTS
Psychoactive drugs which mainly affects sensory
cortex.
Stimulate motor cortex only in high dose.
a) Xanthines and Methylxanthines
[Caffeine]
MOA: Inhibition of phosphodiesterase enzyme.
Degradation of cyclic nucleotides.
Antagonism with adenosine .
Production of dis-inhibitory effect and increased alertness.
Dose:
Dogs : 100-1000mg, hypodermically
b) Amfetamines
Powerful psycho stimulant with risk of drug abuse and drug
dependence.
MOA:
Transportation from extra neuronal space into adrenergic
and dopaminergic nerve.
Into storage vesicles via vesicular monoamine transporter.
Displaces and releases nor-epinephrine and dopamine
through same carrier into synaptic cleft.
Increase in alertness and anorectic effects.
c) Norepinephrine- Dopamine Reuptake
Inhibitors
Used in treatment of attention deficit hyperactivity disorder
(ADHD) & depression.
MOA:
INHIBIT REUPTAKE OF NEUROTRANSMITTERS. (NOR-EPINEPHRINE & DOPAMINE)
ACCUMULATED NEUROTRANSMITTERS IN THE SYNAPSE.
ENHANCED NEUROTRANSMISSION & STIMULANT EFFECT.
d) Ampakines
• Enhance alertness and attention as well as facilitate
learning and memory.
• Used in Alzheimer’s disease, Parkinson’s disease or
other neurological disorders.
• Not known to be used in veterinary medicine.
e) Modafinil And Adrafinil
• Memory improving and mood enhancing
psychostimulants.
• The MOA is not completely known however
they are suggested to be similar to
Amfetamines.
2. BRAINSTEM STIMULANTS/ANALEPTICS
DOXAPRAM
MOA:
Stimulates chemoreceptors in carotid and aortic bodies.
Stimulation of respiratory centre in brain stem.(medulla)
Increase in tidal volume and respiratory rate.
3. CONVULSANTS
A) Strychnine And Brucine
MOA:
Antagonism with glycine. inhibitory neuro-transmitter action.
Enhanced reflex stimulation.
Uncontrolled excitation.
B) PICROTOXIN
MOA:
Antagonist for GABA receptors.
Chloride channel blocked.
Inhibitory neurotransmitters suppressed.
4. PSYCHOTOMIMETICS/HALLUCINOGENS
Alter mood, behavior, thought, emotion & perception.
Mimic the symptoms of pyschosis including delusion.

CNS_stimulants

  • 1.
    Central Nervous SystemStimulants • These Drugs Primarily Stimulate The Nervous System And Improve Certain Brain Functions. • Relatively Nonspecific Drugs In Action And Affect All Parts Of Body When Given In Sufficient Dose. • Adverse Side Effects Are Seen And Potential Of Abuse. So only few drugs are in practice.
  • 2.
    CLASSIFICATION: 1. Psychostimulants/Cerebral Stimulants Xanthines/Methylxanthines Eg: Caffeine  Amfetamines Eg: Amfetamine And Methamphetamine  Norepinephrine-dopamine Reuptake Inhibitors Eg: Methylphenidate  Ampakines Eg: Ampalex And Cardophen  Miscellaneous Drugs Eg: Modafinil And Adrafinil
  • 3.
    2. Brain StemStimulants / Analeptics Eg: Doxapram, Bemegride. 3. Convulsants Eg: Strychine, Brucine, picrotoxin. 4. Psychotomimetics / Hallucinogen Eg: Cannabis, LSD, Mescaline.
  • 4.
    1. PSYCHOSTIMULANTS Psychoactive drugswhich mainly affects sensory cortex. Stimulate motor cortex only in high dose.
  • 5.
    a) Xanthines andMethylxanthines [Caffeine] MOA: Inhibition of phosphodiesterase enzyme. Degradation of cyclic nucleotides. Antagonism with adenosine . Production of dis-inhibitory effect and increased alertness. Dose: Dogs : 100-1000mg, hypodermically
  • 6.
    b) Amfetamines Powerful psychostimulant with risk of drug abuse and drug dependence. MOA: Transportation from extra neuronal space into adrenergic and dopaminergic nerve. Into storage vesicles via vesicular monoamine transporter. Displaces and releases nor-epinephrine and dopamine through same carrier into synaptic cleft. Increase in alertness and anorectic effects.
  • 7.
    c) Norepinephrine- DopamineReuptake Inhibitors Used in treatment of attention deficit hyperactivity disorder (ADHD) & depression. MOA: INHIBIT REUPTAKE OF NEUROTRANSMITTERS. (NOR-EPINEPHRINE & DOPAMINE) ACCUMULATED NEUROTRANSMITTERS IN THE SYNAPSE. ENHANCED NEUROTRANSMISSION & STIMULANT EFFECT.
  • 8.
    d) Ampakines • Enhancealertness and attention as well as facilitate learning and memory. • Used in Alzheimer’s disease, Parkinson’s disease or other neurological disorders. • Not known to be used in veterinary medicine.
  • 9.
    e) Modafinil AndAdrafinil • Memory improving and mood enhancing psychostimulants. • The MOA is not completely known however they are suggested to be similar to Amfetamines.
  • 10.
    2. BRAINSTEM STIMULANTS/ANALEPTICS DOXAPRAM MOA: Stimulateschemoreceptors in carotid and aortic bodies. Stimulation of respiratory centre in brain stem.(medulla) Increase in tidal volume and respiratory rate.
  • 11.
    3. CONVULSANTS A) StrychnineAnd Brucine MOA: Antagonism with glycine. inhibitory neuro-transmitter action. Enhanced reflex stimulation. Uncontrolled excitation.
  • 12.
    B) PICROTOXIN MOA: Antagonist forGABA receptors. Chloride channel blocked. Inhibitory neurotransmitters suppressed.
  • 13.
    4. PSYCHOTOMIMETICS/HALLUCINOGENS Alter mood,behavior, thought, emotion & perception. Mimic the symptoms of pyschosis including delusion.